ArticleHematology reports2012

Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients.

Marjanu Hikmah Elias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.